Basic Information
| LncRNA/CircRNA Name | SNHG7 |
| Synonyms | NA |
| Region | GRCh38_9:136721366-136728184 |
| Ensemble | ENSG00000233016 |
| Refseq | NR_003672 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR, Western blot, RIP, Luciferase reporter assay etc |
| Sample | LUAD tissues,cell lines |
| Expression Pattern | down-regulated |
| Function Description | SNHG7 is downregulated in LUAD and associated with poor survival.SNHG7 inhibits cell proliferation and migration through competitively binding to mir-181. |
| Pubmed ID | 32201260 |
| Year | 2020 |
| Title | The Crosstalk Between lncRNA-SNHG7/miRNA-181/cbx7 Modulates Malignant Character in Lung Adenocarcinoma |
External Links
| Links for SNHG7 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |